Celastrol (Tripterin)
| CAS No.: 34157-83-0 | Request for quotation |  |
|
|
Celastrol (tripterine) is a chemical compound isolated from the root extracts of Tripterygium wilfordii (Thunder god vine) and Celastrus regelii. Celastrol is a pentacyclic triterpenoid and belongs in the family of quinone methides. In in vitro and in vivo animal experiments, celastrol exhibits antioxidant, anti-inflammatory, anticancer, and insecticidal activities. Its effects in humans have not been studied clinically. Celastrol, an active component found in the Chinese herb tripterygium wilfordii has been identified as a neuroprotective agent for neurodegenerative diseases including Parkinson’s disease (PD) through unknown mechanism. Celastrol can induce autophagy, which plays a neuroprotective role in PD. |
|||
Celastrol (Tripterin) Specification (For research use only)
| Appearance | Red powder | Standard Packing | 1g/bag or per customer request | |
| Purity (HPLC) | ≥ 97% | Inventory | Normally we have Celastrol (Tripterin) in stock | |
| Loss on drying | ||||
| Melting Point | 219-230 °C | Celastrol (Tripterin) physical parameters | ||
| Solubility | Soluble in DMSO (>10 mg/ml), ethanol, DMF:PBS(pH 7.2)(1:10), and DMF. Insoluble in water. | CAS No: | 34157-83-0 | |
| Formula | C29H38O4 | |||
| Molecular Weight | 450.61 | |||
| Synonym | 10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid, Tripterin | |||
| Structure |  |
|||
| Certificate of Analysis | Celastrol (Tripterin) COA | |||
| Literature | Celastrol (Tripterin) literature | |||
| MSDS | Celastrol (Tripterin) MSDS | |||
| References: | ||||
| 1. | Upregulating Noxa by ER Stress, Celastrol Exerts Synergistic Anti-Cancer Activity in Combination with ABT-737 in Human Hepatocellular Carcinoma Cells. | |||
| 2. | Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy. DOI: 10.1016/j.neuint.2013.04.005 | |||
| 3. | Celastrol suppresses breast cancer MCF-7 cell viability via the AMP-activated protein kinase (AMPK)-induced p53–polo like kinase 2 (PLK-2) pathway. DOI: 10.1016/j.cellsig.2012.12.005 | |||
| 4. | Celastrol significantly suppressed elevation of the renal function markers and the lipid peroxidation level, alleviated renal tubular damage, and decreased the levels of tumor necrosis factor-a, interleukin-1ß, and monocyte chemotactic protein-1 (MCP-1) messenger RNA in kidney caused by IR. Moreover, celastrol prevented IR-induced expression of pro-inflammatory mediators, which was associated with suppression of nuclear translocation of NF-?B subunit p65. DOI: 10.1016/j.jss.2013.07.048 | |||
| 5. | Celastrol, an anti-cancer drug extracted from natural sources, induces inhibition of cell growth through modulation of ERa in estrogen positive breast cancer cells and is a candidate for use in cancer chemotherapy for human breast cancer. DOI: 10.1016/j.canlet.2010.09.006 | |||
| 6. | Celastrol exhibits potent activity against CML cells bearing wild-type Bcr–Abl or -the T315I-mutant. DOI: 10.1016/j.canlet.2009.09.006 | |||
|
Copyright © 2020 - . All Rights Reserved. |
||||